CDKN1B and cancer: hsa-miR-24-3p, but not hsa-miR-21-5p, also induces growth in human liver cancer cells (HEPG2) (21) and has been reported to promote the growth of cancer cells through inhibition of the cyclin-dependent kinase inhibitor 1B (CDKN1B/p27kip1) (24).